273 related articles for article (PubMed ID: 20971192)
1. Thrombospondin-1 inhibition of vascular smooth muscle cell responses occurs via modulation of both cAMP and cGMP.
Yao M; Roberts DD; Isenberg JS
Pharmacol Res; 2011 Jan; 63(1):13-22. PubMed ID: 20971192
[TBL] [Abstract][Full Text] [Related]
2. Thrombospondin-1 inhibits nitric oxide signaling via CD36 by inhibiting myristic acid uptake.
Isenberg JS; Jia Y; Fukuyama J; Switzer CH; Wink DA; Roberts DD
J Biol Chem; 2007 May; 282(21):15404-15. PubMed ID: 17416590
[TBL] [Abstract][Full Text] [Related]
3. Phosphodiesterase 3A expression is modulated by nitric oxide in rat pulmonary artery smooth muscle cells.
Busch CJ; Graveline AR; Jiramongkolchai K; Liu H; Sanchez LS; Bloch KD
J Physiol Pharmacol; 2010 Dec; 61(6):663-9. PubMed ID: 21224496
[TBL] [Abstract][Full Text] [Related]
4. Nitric oxide attenuates endothelin-1-induced activation of ERK1/2, PKB, and Pyk2 in vascular smooth muscle cells by a cGMP-dependent pathway.
Bouallegue A; Daou GB; Srivastava AK
Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2072-9. PubMed ID: 17644565
[TBL] [Abstract][Full Text] [Related]
5. Thrombospondin-1 antagonizes nitric oxide-stimulated vascular smooth muscle cell responses.
Isenberg JS; Wink DA; Roberts DD
Cardiovasc Res; 2006 Sep; 71(4):785-93. PubMed ID: 16820142
[TBL] [Abstract][Full Text] [Related]
6. Thrombospondin-1-CD47 blockade and exogenous nitrite enhance ischemic tissue survival, blood flow and angiogenesis via coupled NO-cGMP pathway activation.
Isenberg JS; Shiva S; Gladwin M
Nitric Oxide; 2009 Aug; 21(1):52-62. PubMed ID: 19481167
[TBL] [Abstract][Full Text] [Related]
7. CD47 is necessary for inhibition of nitric oxide-stimulated vascular cell responses by thrombospondin-1.
Isenberg JS; Ridnour LA; Dimitry J; Frazier WA; Wink DA; Roberts DD
J Biol Chem; 2006 Sep; 281(36):26069-80. PubMed ID: 16835222
[TBL] [Abstract][Full Text] [Related]
8. Phosphodiesterase 3A expression and activity in the murine vasculature is influenced by NO-sensitive guanylyl cyclase.
Dünnes S; Voussen B; Aue A; Groneberg K; Nikolaev V; Groneberg D; Friebe A
Pflugers Arch; 2018 Apr; 470(4):693-702. PubMed ID: 29294149
[TBL] [Abstract][Full Text] [Related]
9. Endothelium-independent and endothelium-dependent vasorelaxation by a dichloromethane fraction from Anogeissus Leiocarpus (DC) Guill. Et Perr. (Combretaceae): possible involvement of cyclic nucleotide phosphodiesterase inhibition.
Belemnaba L; Ouédraogo S; Auger C; Chataigneau T; Traore A; Guissou IP; Lugnier C; Schini-Kerth VB; Bucher B
Afr J Tradit Complement Altern Med; 2013; 10(2):173-9. PubMed ID: 24146440
[TBL] [Abstract][Full Text] [Related]
10. Effects of various phosphodiesterase-inhibitors, forskolin, and sodium nitroprusside on porcine detrusor smooth muscle tonic responses to muscarinergic stimulation and cyclic nucleotide levels in vitro.
Truss MC; Uckert S; Stief CG; Kuczyk M; Schulz-Knappe P; Forssmann WG; Jonas U
Neurourol Urodyn; 1996; 15(1):59-70. PubMed ID: 8696357
[TBL] [Abstract][Full Text] [Related]
11. The soluble guanylate cyclase stimulator BAY 41-2272 inhibits vascular smooth muscle growth through the cAMP-dependent protein kinase and cGMP-dependent protein kinase pathways.
Joshi CN; Martin DN; Fox JC; Mendelev NN; Brown TA; Tulis DA
J Pharmacol Exp Ther; 2011 Nov; 339(2):394-402. PubMed ID: 21825001
[TBL] [Abstract][Full Text] [Related]
12. Phosphodiesterase 1 regulation is a key mechanism in vascular aging.
Bautista Niño PK; Durik M; Danser AH; de Vries R; Musterd-Bhaggoe UM; Meima ME; Kavousi M; Ghanbari M; Hoeijmakers JH; O'Donnell CJ; Franceschini N; Janssen GM; De Mey JG; Liu Y; Shanahan CM; Franco OH; Dehghan A; Roks AJ
Clin Sci (Lond); 2015 Dec; 129(12):1061-75. PubMed ID: 26464516
[TBL] [Abstract][Full Text] [Related]
13. Thrombospondin-1 supports blood pressure by limiting eNOS activation and endothelial-dependent vasorelaxation.
Bauer EM; Qin Y; Miller TW; Bandle RW; Csanyi G; Pagano PJ; Bauer PM; Schnermann J; Roberts DD; Isenberg JS
Cardiovasc Res; 2010 Dec; 88(3):471-81. PubMed ID: 20610415
[TBL] [Abstract][Full Text] [Related]
14. Role of phosphodiesterase 3 in NO/cGMP-mediated antiinflammatory effects in vascular smooth muscle cells.
Aizawa T; Wei H; Miano JM; Abe J; Berk BC; Yan C
Circ Res; 2003 Sep; 93(5):406-13. PubMed ID: 12919948
[TBL] [Abstract][Full Text] [Related]
15. Calcium-independent and cAMP-dependent modulation of soluble guanylyl cyclase activity by G protein-coupled receptors in pituitary cells.
Kostic TS; Tomić M; Andric SA; Stojilkovic SS
J Biol Chem; 2002 May; 277(19):16412-8. PubMed ID: 11867632
[TBL] [Abstract][Full Text] [Related]
16. Distinct phosphodiesterase 5A-containing compartments allow selective regulation of cGMP-dependent signalling in human arterial smooth muscle cells.
Wilson LS; Guo M; Umana MB; Maurice DH
Cell Signal; 2017 Aug; 36():204-211. PubMed ID: 28506928
[TBL] [Abstract][Full Text] [Related]
17. Resistance to the nitric oxide/cyclic guanosine 5'-monophosphate/protein kinase G pathway in vascular smooth muscle cells from the obese Zucker rat, a classical animal model of insulin resistance: role of oxidative stress.
Russo I; Del Mese P; Doronzo G; Mattiello L; Viretto M; Bosia A; Anfossi G; Trovati M
Endocrinology; 2008 Apr; 149(4):1480-9. PubMed ID: 18079207
[TBL] [Abstract][Full Text] [Related]
18. Vasomotor control in mice overexpressing human endothelial nitric oxide synthase.
van Deel ED; Merkus D; van Haperen R; de Waard MC; de Crom R; Duncker DJ
Am J Physiol Heart Circ Physiol; 2007 Aug; 293(2):H1144-53. PubMed ID: 17496213
[TBL] [Abstract][Full Text] [Related]
19. Gq-mediated Ca2+ signals inhibit adenylyl cyclases 5/6 in vascular smooth muscle cells.
von Hayn K; Werthmann RC; Nikolaev VO; Hommers LG; Lohse MJ; Bünemann M
Am J Physiol Cell Physiol; 2010 Feb; 298(2):C324-32. PubMed ID: 19889965
[TBL] [Abstract][Full Text] [Related]
20. cGMP catabolism by phosphodiesterase 5A regulates cardiac adrenergic stimulation by NOS3-dependent mechanism.
Takimoto E; Champion HC; Belardi D; Moslehi J; Mongillo M; Mergia E; Montrose DC; Isoda T; Aufiero K; Zaccolo M; Dostmann WR; Smith CJ; Kass DA
Circ Res; 2005 Jan; 96(1):100-9. PubMed ID: 15576651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
